Leap Therapeutics Inc (LPTX)
0.4535
+0.07
(+16.88%)
USD |
NASDAQ |
Mar 26, 16:00
0.409
-0.04
(-9.81%)
After-Hours: 04:23
Leap Therapeutics Shareholders Equity (Quarterly): 48.95M for Sept. 30, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Inovio Pharmaceuticals Inc | 68.50M |
| CervoMed Inc | 39.20M |
| AIM ImmunoTech Inc | 2.912M |
| Protalix BioTherapeutics Inc | 43.21M |
| Armata Pharmaceuticals Inc | -48.02M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 65.05M |
| Total Liabilities (Quarterly) | 16.09M |